Personalized Nutrition Companies’ Claims Overhyped: Scientists
Personalized Nutrition Companies’ Claims Overhyped: Scientists
Services promising scientifically tailored supplements or advice abound. Experts say their claims are largely unfounded, although some solid evidence is beginning to emerge.
Services promising scientifically tailored supplements or advice abound. Experts say their claims are largely unfounded, although some solid evidence is beginning to emerge.
direct to consumer
Accuracy of Genotyping Chips Called into Question
Grace Browne | Jul 24, 2019 | 4 min read
Chips used by some direct-to-consumer genetic testing firms display a false positive rate of upwards of 85 percent when screening for rare variants, a new study finds.
Do Devices that Monitor or Zap the Brain Live Up to Their Claims?
Diana Kwon | Jun 18, 2019 | 8 min read
Direct-to-consumer neurotechnologies using EEG or tDCS are becoming increasingly popular, but some scientists are concerned about the lack of evidence for efficacy.
Company Offers Free Whole-Genome Sequencing for Data Sharers
Shawna Williams | Nov 15, 2018 | 2 min read
Nebula Genomics is among the first blockchain-based companies to reward users for contributing personal data for research.
Genes and Blues
Bob Grant | Oct 1, 2018 | 3 min read
Learning about your own genetic idiosyncrasies comes with complex emotions.
Study Finds Inaccuracies in 40 Percent of DTC Genetic Testing Results
Shawna Williams | Mar 28, 2018 | 2 min read
An analysis of 49 patient samples finds high proportions of false positives and misinterpretation.
Theranos CEO Presents New Device
Kerry Grens | Aug 2, 2016 | 2 min read
The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.
Theranos in Criminal Probe
Kerry Grens | Apr 19, 2016 | 1 min read
Federal officials are investigating whether the diagnostics company misled investors.
TS Picks: February 24, 2016
Tracy Vence | Feb 24, 2016 | 1 min read
High-profile stem cell research scandal; forthcoming direct-to-consumer genetics apps; GINA and life insurance
Following FDA OK, 23andMe to Expand Health Prediction
Kerry Grens | Oct 21, 2015 | 2 min read
The personal genomics firm is ramping up its suite of disease-related genetic tests.